# A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

> **NCT00402584** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 304 (actual)

## Conditions studied

- Binge Eating Disorder
- Obesity

## Interventions

- **DRUG:** sibutramine

## Key facts

- **NCT ID:** NCT00402584
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2007-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402584, "A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00402584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*